The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_001379110.1(SLC9A6):c.1083G>A (p.Leu361=)

CA10524772

469632 (ClinVar)

Gene: SLC9A6
Condition: Christianson syndrome
Inheritance Mode: X-linked inheritance
UUID: 83d8c4a4-679b-424d-bc07-259435d6b659
Approved on: 2024-02-23
Published on: 2024-03-31

HGVS expressions

NM_001379110.1:c.1083G>A
NM_001379110.1(SLC9A6):c.1083G>A (p.Leu361=)
NC_000023.11:g.136016647G>A
CM000685.2:g.136016647G>A
NC_000023.10:g.135098806G>A
CM000685.1:g.135098806G>A
NC_000023.9:g.134926472G>A
NG_017160.1:g.36221G>A
ENST00000370695.8:c.1239G>A
ENST00000370701.6:c.1083G>A
ENST00000630721.3:c.1083G>A
ENST00000636092.1:c.1083G>A
ENST00000636347.1:c.1083G>A
ENST00000636798.1:n.518G>A
ENST00000637195.1:c.987G>A
ENST00000637234.1:c.1083G>A
ENST00000637581.1:c.1083G>A
ENST00000643775.1:n.1026G>A
ENST00000675856.1:n.1026G>A
ENST00000678163.1:c.1239G>A
ENST00000370695.6:c.1239G>A
ENST00000370698.7:c.1143G>A
ENST00000370701.5:c.1083G>A
NM_001042537.1:c.1239G>A
NM_001177651.1:c.1083G>A
NM_006359.2:c.1143G>A
NM_001330652.1:c.987G>A
NM_001177651.2:c.1083G>A
NM_001330652.2:c.987G>A
NM_006359.3:c.1143G>A
NM_001042537.2:c.1239G>A
NM_001400909.1:c.1083G>A
NM_001400910.1:c.1083G>A
NM_001400911.1:c.1083G>A
NM_001400912.1:c.1083G>A
NM_001400913.1:c.987G>A

Benign

Met criteria codes 5
BP4 BP7 BP5_Strong BS2 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for SLC9A6 Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the p.Leu381= variant in SLC9A6 (NM_006359.2) is 0.024% in European (Non-Finnish) sub population in gnomAD v2, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The silent p.Leu381= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7). The p.Leu381= variant is observed in the hemizygous state in at least 2 unaffected individuals (internal database - GeneDx) (BS2_strong). The p.Leu381= variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx, internal database - Invitae) (BP5_strong). In summary, the p.Leu381= variant in SLC9A6 is classified as benign based on the ACMG/AMP criteria (BS1, BP4, BP7, BS2_strong, BP5_strong).
Met criteria codes
BP4
The silent p.Leu381=variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7).
BP7
The silent p.Leu381=variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7).
BP5_Strong
The p.Leu381= variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx, internal database - Invitae) (BP5_Strong).
BS2
The p.Leu381= variant is observed in the hemizygous state in at least 2 unaffected individuals (internal database - GeneDx) (BS2_Strong).
BS1
The allele frequency of the p.Leu381= variant in SLC9A6 (NM_006359.2) is 0.024% in European (non-Finnish) sub population in gnomAD v2, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.